VILLA GUARDIA (COMO), Italy, June 15, 2011 (GLOBE NEWSWIRE) -- Gentium S.p.A. (Nasdaq:GENT) announced the appointment of Link Pharmaceuticals as exclusive distributor of Defibrotide in Australia and New Zealand. Under the terms of the agreement, Link will be responsible for managing named patient requests.
